Regio- and stereoselective synthesis of aminoinositols and 1,2-diaminoinositols from conduritol B epoxide

Journal of Organic Chemistry

Volumn 70, Issue 20, 2005, Pages 7829-7840

  Serrano, Pedro ^a,b   Llebaria, Amadeu ^b   Delgado, Antonio ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; AMINES; ISOMERIZATION; ORGANIC COMPOUNDS; SYNTHESIS (CHEMICAL);

AMINOINOSITOLS; EPOXIDES; REGIOSELECTIVITY; STEREOSELECTIVE;

AMINO ACIDS;

1,2 DIAMINOINOSITOL; AMINOINOSITOL; AZIRIDINE DERIVATIVE; EPOXIDE; INOSITOL DERIVATIVE; TETRA O BENZYLCONDURITOL B EPOXIDE; UNCLASSIFIED DRUG;

ARTICLE; AZIDOLYSIS; CHEMICAL MODIFICATION; CHEMICAL REACTION; CIS ISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

AMINES; EPOXY COMPOUNDS; INDICATORS AND REAGENTS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; STEREOISOMERISM;

EID: 25444489938     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo050521a     Document Type: Article

References (73)

1. Ogawa, S. In Carbohydrates in Drug Design; Witczak, Z., Nieforth, K., Eds.; Dekker: New York, 1997; pp 433-469.
2. For examples of synthesis of cyclitol derivatives, see: (a) Gravier-Pelletier, C.; Maton, W.; Dintinger, T.; Tellier, C.; Le Merrer, Y. Tetrahedron 2003, 59, 8705-8720.
3. (b) Miyabe, H.; Nishiki, A.; Naito, T. Chem. Pharm. Bull. 2003, 51, 100-103.
4. (c) Gomez, A. M.; Moreno, E.; Valverde, S.; Lopez, J. C. Tetrahedron Lett. 2002, 43, 7863-7866.
5. (d) Marco-Contelles, J.; Rodriguez-Fernandez, M. C. R. Acad. Sci. Ser. II C 2001, 4, 443-452.
6. (e) Sellier, O.; Van de Weghe, P.; Le Nouen, D.; Strehler, C.; Eustache, J. Tetrahedron Lett. 1999, 40, 853-856.
7. Eguchi, T.; Sasaki, S.; Huang, Z.; Kakinuma, K. J. Org. Chem. 2002, 67, 3979-3984.
8. Agnelli, T.; Sucheck, S. J.; Marby, K. A.; Rabuka, D.; Yao, S. L.; Sears, P. S.; Liang, F. S.; Wong, C. H. Angew. Chem., Int. Ed. 2004, 43, 1562-1566.
9. Verhelst, S. H. L.; Wennekes, T.; van der Marel, G. A.; Overkleeft, H. S.; van Boeckel, C. A. A.; van Boom, J. H. Tetrahedron 2004, 60, 2813-2822.
10. (a) Schilling, S.; Rinner, U.; Chan, C.; Ghiviriga, I.; Hudlicky, T. Can. J. Chem. 2001, 79, 1659-1667.
11. (b) Frontier, A. J.; Raghavan, S.; Danishefsky, S. J. J. Am. Chem. Soc. 2000, 122, 6151-6159.
12. (c) Suzuki, T.; Tanaka, S.; Yamada, I.; Koashi, Y.; Yamada, K.; Chida, N. Org. Lett. 2000, 2, 1137-1140.
13. Carbohydrate Mimics, Concepts and Methods; Chapleur, Y., Ed.; Wiley-VCH: Weinheim, 1998.
14. For recent examples of inositol derivatives as enzyme inhibitors see: (a) Bashir-Uddin Surfraz, M.; Miller, D. J.; Gani, D.; Allemann, R. K. Tetrahedron Lett. 2003, 44, 7677-7679.
15. (b) Mills, S. J.; Potter, B. V. L. Bioorg. Med. Chem. 2003, 11, 4245-4253.
16. (c) Mills, S. J.; Backers, K.; Erneux, C.; Potter, B. Org. Biomol. Chem. 2003, 1, 3546-3556.
17. (d) Chang, Y.; Choi, G.; Bae, Y.; Burdett, M.; Moon, H.; Lee, J.; Gray, N.; Schultz, P.; Meijer, L.; Chung, S.; Choi, K.; Suh, P.; Ryu, S. ChemBioChem 2002, 3, 897-901.
18. (e) Ahn, Y.; Chung, S. Bull. Korean Chem. Soc. 2002, 23, 515-517.
19. (a) Clarke, J. H. Curr. Biol. 2003, 13, R815-817.
20. (b) Brunn, G.; Fauq, A. H.; Chow, S.; Kozikowski, A. P.; Gallegos, A.; Powis, G. Cancer Chemother. Pharmacol. 1994, 35, 71-79
21. (c) Panayotou, G.; Waterfield, M. D.; Clarke, J. H. Trends Cell Biol. 1992, 2, 358-360.
22. (d) Powis, G.; Aksoy, I. A.; Melder, D. C.; Aksoy, S.; Eichinger, H.; Fauq, A. H.; Kozikowski, A. P. Cancer Chemother. Pharmacol. 1991, 29, 95-104.
23. Paul, B. J.; Willis, J.; Martinot, T. A.; Ghiviriga, I.; Abboud, K. A.; Hudlicky, T. J. Am. Chem. Soc. 2002, 124, 10416-10426.
24. Azev, V. N.; D'Alarcao, M. J. Org. Chem. 2004, 69, 4839-4842.
25. Suami, T.; Shiio, T.; Kazuo, O.; Kunisuke, I. (Ajinomoto Co. Inc.). Japanese Patent Application JP 86-161529, 1988.
26. Suami, T.; Takeshi, S. (Ajinomoto Co. Inc.). Japanese Patent Application JP85-127551, 1986.
27. Ouadi, A.; Loussouarn, A.; Morandeau, L.; Remaud, P.; Faivre-Chauvet, A.; Webb, J.; Gestin, J.-F. Eur. J. Med. Chem. 2004, 39, 467-472.
28. Menger, F. M. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 4818-4822.
29. For trans-1,2-diaminocyclitols from N-tosyl or N-acyl aziridines see: (a) Reference 7.
30. (b) Paul, B. J.; Martinot, T. A.; Willis, J.; Hudlicky, T. Synthesis-Stuttgart 2001, 952-956.
31. (c) Paulsen, H.; Mielke, B. Liebigs Ann. Chem. 1990, 169-180.
32. (d) Kresze, G.; Melzer, H. Liebigs Ann. Chem. 1981, 1874-1879.
33. From reaction of a trans-1,2-dimesylate with sodium azide, see: (e) De Almeida, M. V.; Figueiredo, R. M.; Dos Santos, H. F.; Da Silva, A. D.; De Almeida, W. B. Tetrahedron Lett. 2001, 42, 2767-2769.
34. For general synthesis of trans-1,2-diaminocyclohexane derivatives from N-substituted aziridinecyclohexane derivatives, see: (f) Watson, I. D.; Yudin, A. K. J. Org. Chem. 2003, 68, 5160-5167.
35. (g) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew Chem., Int. Ed. 2001, 40, 2004-2021.
36. (h) Karpf, M.; Trussardi, R. J. Org. Chem. 2001, 66, 2044-2051.
37. (i) Mitchell, J. M.; Finney, N. S. Tetrahedron Lett. 2000, 41, 8431-8434.
38. Kresze, G.; Weisz, M.; Dittel, W. Liebigs Ann. Chem. 1984, 203-212.
39. Guedat, P.; Spiess, B.; Schlewer, G. Tetrahedron Lett. 1994, 35, 7375-7378.
40. Egido-Gabás, M.; Serrano, P.; Casas, J.; Llebaria, A.; Delgado, A. Org. Biomol. Chem. 2005, 3, 1195-1201.
41. For the sake of simplicity, the synthetic methodology described in this work has been carried out from the easily available racemic tetra-O- benzylconduritol B epoxide 9, obtained from (±)-conduritol B by epoxidation (MCPBA, MeOH) followed by benzylation (BnBr, NaH, DMF). For the synthesis of enantiopure 9, see ref 22. For general syntheses of enantiopure conduritol B epoxide derivatives from the chiral pool, see: (a) Falshaw, A.; Hart, J. B.; Tyler, P. C. Carbohydr. Res. 2000, 329, 301-308.
42. (b) Takahashi, H.; Iimori, T.; Ikegami, S. Tetrahedron Lett. 1998, 39, 6939-6942.
43. (c) Watanabe, Y.; Mitani, M.; Ozaki, S. Chem. Lett. 1987, 123-126.
44. Enantiopure conduritol B from deracemization of conduritol B tetracarbonate: Trost, B. M.; Patterson, D. E.; Hembre, E. J. Chem. Eur. J. 2001, 7, 3768-3775.
45. (a) Bartok, M.; Lang, K. L. In Small Ring Heterocycles; Hassner, A., Ed.; Wiley: New York, 1985.
46. (b) Eliel, E. L.; Allinger, N. L.; Angyal, S. J.; Morrison, G. A. Topics in Stereochemistry; Interscience: New York, 1965; p 102.
47. (c) Rickborn, B.; Murphy, D. K. J. Org. Chem. 1969, 34, 3209.
48. Serrano, P.; Llebaria, A.; Delgado, A. J. Org. Chem. 2002, 67, 7165-7167.
49. For the use of chelation-controlled aminolysis and azidolysis of 1,2-epoxycyclohexanes bearing remote polar groups, see Calvani, F.; Crotti, P.; Gardelli, C.; Pineschi, M. Tetrahedron 1994, 50, 12999-13022 and references therein.
50. A theoretical study of this reaction has been carried out. Serrano, P.; Llebaria, A.; Vazquez, J.; de Pablo, J.; Anglada, J. M.; Delgado, A. Chem. Eur. J. 2005, 11, 4465-4472.
51. In all cases, the major conformation is assumed to be that imposed by the "all-equatorial" disposition of the OBn groups.
52. For epoxide opening under nonchelating conditions, see, inter alia: (a) Uzan, R.; Letellier, P.; Ralainairina, R.; Beaupère, D. Synthesis 1994, 925-930.
53. (b) Nakata, M.; Chong, C.; Niwata, Y.; Toshima, K.; Tatsuta, K. J. Antibiot. 1993, 46, 1919-1922.
54. (c) Letellier, P.; Rallainirina, R.; Uzan, R.; Beaupère, D. Tetrahedron Lett. 1994, 35, 4555-4558.
55. (d) Ogawa, S.; Chida, N.; Suami, T. J. Org. Chem. 1983, 48, 1203-1207.
56. Formation of minor amounts of azido alcohol 16 had already been observed in reaction of mesylate 14 with other nucleophiles in DMF (unpublished results from our group).
57. Imidate esters salts have been proposed as reaction intermediates for the conversion of alcohols into formate esters. See, for example: (a) Barluenga, J.; Campos, P. J.; González-Núñez, E.; Asensio, G. Synthesis 1985, 426-428.
58. (b) Riley, A. M.; Jenkins, D. J.; Potter, B. V. L. Carbohydr. Res. 1998, 314, 277-281. Although we have never observed the corresponding formate ester, its formation and in situ hydrolysis along the reaction course cannot be ruled out.
59. 2O system, see: Angyal, S. J.; Odier, L. Carbohydr. Res. 1980, 80, 203-206.
60. Mesylate 15 also failed to react with other nucleophiles, such as sodium azide, potassium phthalimide (see text), or benzoic acid/CsF, whereas the corresponding triflate A gave the anti elimination adduct B. Diagram presented
61. Eliel, E.; Ro, R. S. J. Am. Chem. Soc. 1957, 79, 5995-6000.
62. For related examples of the effect of stereoelectronic effects on the reactivity of inositol derivatives, see: (a) Guidot, J. P.; Legall, T. J. Org. Chem. 1993, 58, 5271-5273.
63. (b) Shing, T. K.; Wan, L. H. J. Org. Chem. 1996, 61, 8468-8479.
64. Benedetti, F.; Norbedo, S. Tetrahedron Lett. 2000, 41, 10071-10074.
65. For a similar process, see: Rohloff, J. C.; Kent, K. M.; Postich, M. J.; Becker, M. W.; Chapman, H. H.; Kelly, D. E.; Lew, W.; Louie, M. S.; McGee, L. R.; Prisbe, E. J.; Schultze, L. M.; Yu, R. H.; Zhang, L. J. J. Org. Chem. 1998, 63, 4545-4550.
66. The reactivity of mesylate 14 with nonanionic nitrogen nucleophiles was somewhat sluggish. Thus, no reaction was observed with butylamine or diethylamine under forcing conditions (10 equiv, DMF, 90 °C, 48 h, sealed tube). On the contrary, reaction of 14 with sodium azide (DMF, 100 °C) afforded the expected cis-diazide, whose spectroscopic data matched those described in the literature (ref 18).
67. The relative configuration present in mesylates 14 and 26, in which the mesyloxy group shows a trans relationship with respect to both of the substituents on the adjacent carbon atoms, seems to be the only one operative for intermolecular substitution with anionic nitrogen nucleophiles. Compare, for example, the reactivity of the above mesylates with that of diastereomeric mesylate 15 (see text) or triflate A, as indicated in ref 30.
68. For a similar sequence leading to differently functionalized N,N′-cis-1,2-diaminocyclohexane derivatives, see: Govindaraju, T.; Gonnade, R. G.; Bhadbhade, M. M.; Kumar, V. A.; Ganesh, K. N. Org. Lett. 2003, 5, 3013-3016.
69. Bidimensional nOe experiments from azido N-octanoyl derivative 35 were also in agreement with the stereochemical assignment for precursor azido amine 23 (see Supporting Information).
70. Pretsch, E.; Clerc, T.; Seibl, J.; Simon, W. Tablas para la determinación estructural par métodos espectroscópicos; Springer-Verlag Ibérica: Barcelona, 1998.
71. Polybenzylated aminocyclitols have been reported to be poisonous for the Pd/C catalysed hydrogenolysis of benzyl ethers (Surfraz, M. B. U.; Akhtar, M.; Allemann, R. K. Tetrahedron Lett. 2004, 45, 1223-1226).
72. Elamin, B.; Anantharamaiah, G. M.; Royer, G. P.; Means, G. E. J. Org. Chem. 1979, 44, 3442-3444.
73. This unexpected chemoselectivity can be used for the selective functionalization of the amino group. The reductive animation of 36 with n-octanal to afford amino amide 43 (see below) is illustrative. (Diagram presented)